Surging US APH claims are likely to hit European insurers

Research by run-off specialist Ruxley Ventures research has revealed that surging US APH claims are likely to hit European insurers. The research found that US courts are awarding substantially higher mesothelioma damages, and new sources of claims continue to be identified. US insurers are being forced to increase their US APH reserves, while European insurers’ US APH reserves have shown no significant movement. Ruxley said that increasing claims awards, combined with the implementation of Solvency II, are likely to hit European insurers’ US APH reserve requirements.